Radiation therapies applied to glioblastoma: proton MR spectroscopy and diffusion MR imaging monitoring to predict tumor response to interstitial photodynamic therapy ; Thérapies par rayonnements appliquées au cas du glioblastome : Intérêt du suivi par spectroscopie et imagerie de diffusion par résonance magnétique.Vers une thérapie bimodale
Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Book
Titel:
Radiation therapies applied to glioblastoma: proton MR spectroscopy and diffusion MR imaging monitoring to predict tumor response to interstitial photodynamic therapy ; Thérapies par rayonnements appliquées au cas du glioblastome : Intérêt du suivi par spectroscopie et imagerie de diffusion par résonance magnétique.Vers une thérapie bimodale
Erschienen:
[Erscheinungsort nicht ermittelbar]: HAL CCSD, 2016
Sprache:
Französisch
Entstehung:
Hochschulschrift:
Dissertation, HAL CCSD, 2016
Anmerkungen:
Beschreibung:
The limitations encountered today in the treatment of glioblastoma (GBM) involve the quality of the resection on which depends prognosis and the lack of local control of the tumor, knowing that relapses occur in 80% of cases in the radiotherapy target tumor volume. In this context, interstitial photodynamic therapy (iPDT) is a promising additional tool that would allow to improve local control of the tumor. The first part of this thesis focused on the longitudinal follow-up by Magnetic Resonance Imaging (MRI) of the post-iPDT tumor response in a nude rat model of orthotopic xenograft of human GBM cell line. MRI and Magnetic Resonance Spectroscopy (MRS) monitoring provided early indicators of the effectiveness of treatment, for discriminate from one daypost-IPDT non-responders from responders animals. However, one of the limitations of PDT remains the low penetration of visible light used to activate the photosensitizer and induce reactions of photo-oxidation. This is why the second part of this research focused on the evaluation of a new concept called PDTX" for coupling the photodynamic effect with radiotherapy effect for a photodynamic radiotherapy, playing especially on the complementarity of reactive species of oxygen generated and RX-induced effects. For this, we validated the interest of an AGuIX®-type hybrid nanoparticle composed of terbium and porphyrin, terbium being the scintillator capable of being excited by X-rays and emits photons at an appropriate wavelength in order to activate the photosensitizer. The energy transfer FRET (Förster Resonance Energy Transfer) between terbium and porphyrin was highlighted. In vitro results demonstrate the therapeutic potential of this new nano-object at low-energy.